Stockreport

Lumos Pharma to Report Full Year 2023 Financial Results and Host Conference Call on March 7, 2024

Lumos Pharma, Inc.  (LUMO) 
PDF AUSTIN, Texas, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing an oral therapeutic candidate for Pediatric Gr [Read more]